Sarepta Therapeutics (SRPT) Notes Payables (2012 - 2015)

Sarepta Therapeutics' Notes Payables history runs 4 years deep, the most recent figure standing at $2.5 million for Q4 2015.

• On a quarterly basis, Notes Payables changed 0.04% year-over-year to $2.5 million in Q4 2015; TTM through Dec 2015 was $2.5 million, a 0.04% change from a year earlier, with the FY2015 full-year figure at $2.5 million, changed 0.04% from the prior year.
• Notes Payables advanced to $2.5 million in Q4 2015 per SRPT's latest filing, from $2.5 million in the prior quarter.
• Across five years, Notes Payables topped out at $65.2 million in Q4 2012 and bottomed at $2.4 million in Q3 2014.
• The 4-year median for Notes Payables is $4.9 million (2015), against an average of $13.5 million.
• Across the five-year window, Notes Payables slumped 93.29% in 2014 and increased 1.61% in 2015, its largest moves.
• Year by year, Notes Payables stood at $65.2 million in 2012, then tumbled by 86.19% to $9.0 million in 2013, then tumbled by 72.33% to $2.5 million in 2014, then grew by 0.04% to $2.5 million in 2015.
• Per Business Quant, the three latest SRPT Notes Payables figures stand at $2.5 million (Q4 2015), $2.5 million (Q3 2015), and $4.9 million (Q2 2015).